Y-Intercept (HK)
ETRA

Y-Intercept (HK)’s Electra Therapeutics, Inc. Common stock ETRA Stock Holding History

Y-Intercept (HK)’s Portfolio ETRA Stock Details ETRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$237K Buy
+21,103
New +$260K 0.01% 1451

Other funds holding ETRA

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Monashee Investment Management
Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return

Y-Intercept (HK)'s ETRA Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Electra Therapeutics, Inc. Common stock (ETRA) in Q3 2026: 21,103 shares worth $237K. The stake represents 0.01% of the portfolio and ranks #1451 among its holdings.

4 funds tracked by Wall St. Rank hold ETRA as of Q3 2026.

  • Y-Intercept (HK) held 21,103 shares of Electra Therapeutics, Inc. Common stock worth $237K as of Q3 2026.
  • Electra Therapeutics, Inc. Common stock was a new Y-Intercept (HK) position in Q3 2026.
  • Electra Therapeutics, Inc. Common stock made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1451 holding.
  • 4 funds tracked by Wall St. Rank held Electra Therapeutics, Inc. Common stock as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.